See All Slides - tctmd.com

Slides

Presentation TCT 2014

What Amount of Intravenous Fluid Produces Maximum Hemodynamic Benefit in Tamponade Patients

Presenter: Vikas Singh

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

Use Of Optical Coherence Tomography To Study The Role Of Non-Compliant Balloon Post-Dilation In Optimization Of Bioresorbable Vascular Scaffolds

Presenter: Jaya Chandrasekhar

September 16, 2014

Presentation TCT 2014

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Presenter: Devesh Amatya

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting In Patients With Contra-lateral Stenosis Or Occlusion_ A Single Center Experience Of More Than 1100 Cases

Presenter: J?rgen Kammler

September 16, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation TCT 2014

Optimized Immediate Angiographic Result After Percutaneous Coronary Intervention for Chronic Total Occlusion Is Associated With Lower Restenosis Rates_ A Single Centre Experience_

Presenter: Karl ISAAZ

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

Diagnostic Accuracy Of Optical Coherence Tomography Compared To Fractional Flow Reserve For The Severity Assessment Of Coronary Lesions: A Bivariate Meta-analysis

Presenter: Georgios Siontis

September 16, 2014

Presentation TCT 2014

Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-segment Elevation

Presenter: Josephine Warren

September 16, 2014

Advertisement

Slides

What Amount of Intravenous Fluid Produces Maximum Hemodynamic Benefit in Tamponade Patients

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Use Of Optical Coherence Tomography To Study The Role Of Non-Compliant Balloon Post-Dilation In Optimization Of Bioresorbable Vascular Scaffolds

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Carotid Artery Stenting In Patients With Contra-lateral Stenosis Or Occlusion_ A Single Center Experience Of More Than 1100 Cases

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Optimized Immediate Angiographic Result After Percutaneous Coronary Intervention for Chronic Total Occlusion Is Associated With Lower Restenosis Rates_ A Single Centre Experience_

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Diagnostic Accuracy Of Optical Coherence Tomography Compared To Fractional Flow Reserve For The Severity Assessment Of Coronary Lesions: A Bivariate Meta-analysis

Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-segment Elevation

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content